Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-adrenergic blockers. Choosing among them.

R E Vlietstra, M D McGoon

    Postgraduate Medicine
    |September 1, 1984
    PubMed
    Summary

    Beta-adrenergic blocking agents vary in potency, selectivity, and lipid solubility, impacting drug action and side effects. Understanding these differences is key for effective patient treatment and optimized dosage scheduling.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    REVEAL: a contemporary US pulmonary arterial hypertension registry.

    European respiratory review : an official journal of the European Respiratory Society·2012
    Same author

    The assessment of pulmonary hypertension.

    Clinics in chest medicine·2001
    Same author

    Report of the NASPE/NHLBI round table on future research directions in atrial fibrillation.

    Pacing and clinical electrophysiology : PACE·2001
    Same author

    Breath-holding spells associated with significant bradycardia: successful treatment with permanent pacemaker implantation.

    Pediatrics·2001
    Same author

    Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2001
    Same author

    Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.

    Circulation·2000

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine

    Background:

    • Beta-adrenergic blocking agents are widely used medications.
    • Existing agents exhibit notable variability in key pharmacological properties.

    Purpose of the Study:

    • To highlight the significant clinical differences among available beta-adrenergic blocking agents.
    • To inform optimal therapeutic selection and dosage strategies.

    Main Methods:

    • Comparative analysis of pharmacological properties of six beta-adrenergic blocking agents.
    • Review of clinical implications related to potency, selectivity, partial agonist effect, lipid solubility, and cost.

    Main Results:

    • Significant variations exist in potency, selectivity, partial agonist effect, and lipid solubility among the agents.
    • These differences directly influence drug action, dosage, and side effect profiles.

    Conclusions:

    • Careful selection of beta-adrenergic blocking agents based on individual patient needs and drug characteristics is crucial.
    • Optimizing treatment requires consideration of agent-specific properties to enhance efficacy and minimize adverse events.

    Related Experiment Videos